Bayer sells Eu2.3bn CB to ease Schering rating cuts
German pharmaceuticals company Bayer lit up the European convertible bond market on Wednesday by issuing the largest deal for three years, a Eu2bn issue to part-refinance its Eu16.3bn agreed acquisition of German rival Schering.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
